MedPath

In vivo imaging of amyloid-beta deposition in Alzheimer's disease

Completed
Conditions
hersenaandoening
cognitive dysfunction
dementia
Registration Number
NL-OMON33273
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

- Diagnosed with probable Alzheimer's disease
- Diagnosed as memory complainer
- Capable of giving informed consent

Exclusion Criteria

- Contra-indication to MRI scanning:
• Claustrophobia
• Pacemakers and defibrillators
• Nerve stimulators
• Intracranial clips
• Intraorbital or intraocular metallic fragments
• Cochlear implants
• Ferromagnetic implants
• Hydrocephaluspump
• Intra-utrine device
• An iron wire behind the teeth
• Permanent make-up
• Tattoos above the shoulders
- MMSE < 19 points
- Severe physical restrictions (completely wheelchair dependent)
- Fear or problems during the 3T MRI scan
- Age above 90

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter will be a qualitative measure of the presence of<br /><br>distinct hypointense cortical foci and an inhomogeneous aspect of the cortex.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameter will be a quantitative measure of susceptibility<br /><br>related changes in the cortex.</p><br>
© Copyright 2025. All Rights Reserved by MedPath